News
The analyst behind the change is now bullish on Teva's future. A positive change in recommendation from a well-known bank was ...
In his first term, pharmaceutical companies took the "most favored nation" policy to court over the White House's effort to slash costs for patients.
Global investment firm TPG has signed a legally binding agreement to purchase a 35% ownership in SCHOTT Poonawalla, the joint venture between Serum Institute of India (SII) and Germany-based SCHOTT ...
Good morning, everyone, and welcome to the Viatris Q1 2025 earnings call. (Operator Instructions) Please also note, today's event is being recorded. At this time, I'd like to turn the floor over to ...
TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...
Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAGR of 7.5%. BURLINGAME, CA, UNI ...
Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...
SCHOTT Pharma, a provider of drug containment solutions and delivery systems for injectable drugs, announced that TPG — a ...
TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...
Global alternative asset management firm TPG has agreed to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII), according to an announcement on Tuesday. S ...
Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results